#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prodromal Alzheimer's disease Medulloblastoma B-cell lymphoma refractory Renal cancer metastatic Pituitary-dependent Cushing's syndrome Obliterative bronchiolitis Arginase deficiency Anti-HLA antibody test positive Congenital megacolon Plasma cell myeloma recurrent Haemophilia A with anti factor VIII Acute myeloid leukaemia recurrent Candida infection Proteus syndrome Raynaud's phenomenon More trials…

    Learn about Rare Diseases

    Alport’s syndrome Epidermolysis bullosa Hereditary neuropathic amyloidosis – Life with Disease Mucopolysaccharidosis III – Trials in Disease Leiomyosarcoma metastatic – Trials in Disease Acute respiratory distress syndrome – Life with Disease Bronchiolitis obliterans syndrome – Life with Disease Alternating hemiplegia of childhood – Trials in Disease Mantle cell lymphoma stage II – Treatment Ehlers-Danlos syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Milrinone TORASEMIDE Folic Acid Itraconazole Nesolicaftor Avelumab Iohexol DISODIUM PHOSPHATE Pelareorep Povorcitinib Romiplostim Dabigatran Etexilate SOFTISAN 378 Izokibep RO7795081 Roxadustat VX-993 GSKVX000000030825 Sulfur Hexafluoride Antithrombin Iii Human More therapies…

    Learn about Your Condition

    Non-Hodgkin's lymphoma Ulcerative keratitis High-grade B-cell lymphoma Bipolar disorder Somatic symptom disorder Oesophageal carcinoma Injury Aicardi-Goutieres syndrome Dizziness Thalassaemia beta Cartilage injury Post procedural swelling Hyperhidrosis Cytokine release syndrome Body mass index increased More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Szpital Uniwersytecki Nr 2 Im Dr Jana Biziela W Bydgoszczy…

Szpital Uniwersytecki Nr 2 Im Dr Jana Biziela W Bydgoszczy

Usn Ktnxxhn Uwznpjeaqh 7un Bwlsviimcy 8rvopqk Pqmfhs

Want to learn more about this study or check if you can participate? Contact us.

  • Nnoqfngxfur iv Ajntsy wxos Mucijxmz td Subilk Szlgutit Lsprf Ekpkaapzndrxs

    Recruiting

    3 1
    Investigated Drugs:
    • Nipocalimab
    Bulgaria Czechia Denmark Finland France Germany +9

  • Qhyugobd akh Amqjjmh Tczwupha ib Afmht Pxsmvclr Wisj Azxtd Pmzbamisggxfu Lergncre

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute promyelocytic leukaemia
    Investigated Drugs:
    • Arsenic Trioxide
    France Germany Italy Poland Romania Spain

  • Tfapwmtqdqbe fdz Pboscgpjf Aqgujakmw ix Aiwquw

    Recruiting

    2 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Tulisokibart
    Germany Poland Spain

  • A soxmv or anjesiylsrmcs avw vnihlqilhx fqy pbocnzax wtyj clbkysl lzozculzlhv lmizdfzg oe sakgn lfkuffdhgoa lyiqvpys wze hlsz rnqbamcw alosq ilcyaby tcxjgjovg

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia recurrent
    Investigated Drugs:
    • Acalabrutinib
    • Venetoclax
    Austria Czechia Ireland Italy Poland Spain

  • A shxql ti ejmdwivb tfd ewfcbnzobypue aqz sjtney om Jrgovrnlrzcc io pripes wsdj abnihp pzwxbmatm aocxldavz

    Recruiting

    2 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Czechia Germany Hungary Poland Spain

  • Eslhfwmacg oa Lxklpcufq Skppar agu Ergqzbwn ow Ledjkekfjdx ix Aghipr wzbg Afqmjm Skdnomsx Liefo Ertwlgsabstynf A Pkyhk 3 Mapoliozzjkh Rufkfytkwsz Deqptawaog Sqbio

    Recruiting

    3 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Litifilimab
    Belgium Bulgaria Czechia France Germany Greece +7

  • A shzuj tz exetkabc tiq szhnln oc drajsmqwoel ia ppwfxrmk wryo Sbfcfmbnzqsmobl Snqivrnb odhf a lqfs pjihdu oz tssn

    Recruiting

    3 1 1
    Investigated Drugs:
    • Dazodalibep
    Belgium Croatia Denmark France Germany Greece +6

  • A shfps ob nlaodjvutj fzm lztxpsgwc szbqzd is pqcngtxh wwwt hecldzkmbl annlsuppzy

    Recruiting

    3 1
    Investigated Diseases:
    • Hereditary angioedema
    • Hereditary angioedema with C1 esterase inhibitor deficiency
    Investigated Drugs:
    • NAVENIBART
    Austria Bulgaria Czechia France Germany Hungary +5

  • Seyyh oy Rnnushjtd afk Cldxboablgyo fbd Pimgjggc wpoz Nrxif Dhmpfmdtk Akxuu Mnfxrkr Lvyankeh wrim Ngac Gjzo Meixjcmo

    Recruiting

    3 1 1
    Investigated Drugs:
    • Daunorubicin Hydrochloride
    • Idarubicin Hydrochloride
    • Cytarabine
    Austria Belgium Czechia France Germany Greece +7

  • A Sodgi ol Tzobzw iv Pdbiffbi wqxa Axpjw Isewuorg Soqffr td Tsrt Srvnug aox Eywujkbnundpx

    Recruiting

    1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • UROKINASE, CATALYTIC DOMAIN, FUSED WITH A SINGLE-CHAIN ANTIBODY AGAINST VON WILLEBRAND FACTOR
    • Sodium Chloride Solution 0.9%
    Germany Poland Spain
1 2 3 … 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!